Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 67

1.

TCT-312 Increased Cardiac Death and Stent Thrombosis in Chronic Obstructive Pulmonary Disease Patients Undergoing Percutaneous Coronary Intervention. An analysis of the BASKET-PROVE I and II trials.

Jatene T, Biering-Sørensen T, Nochioka K, Mangione F, Hansen K, Sørensen R, Jensen JS, Jørgensen P, Jeger R, Kaiser C, Pfisterer M, Galatius S.

J Am Coll Cardiol. 2016 Nov 1;68(18S):B129. doi: 10.1016/j.jacc.2016.09.443. No abstract available.

PMID:
27969656
2.

Frequency of Cardiac Death and Stent Thrombosis in Patients With Chronic Obstructive Pulmonary Disease Undergoing Percutaneous Coronary Intervention (from the BASKET-PROVE I and II Trials).

Jatene T, Biering-Sørensen T, Nochioka K, Mangione FM, Hansen KW, Sørensen R, Jensen JS, Jørgensen PG, Jeger R, Kaiser C, Pfisterer M, Galatius S; BASKET-PROVE Investigators..

Am J Cardiol. 2017 Jan 1;119(1):14-19. doi: 10.1016/j.amjcard.2016.09.013.

PMID:
27788931
3.

Stroke survivors' experiences of communication with healthcare providers in long-term care settings: a systematic review protocol.

Sørensen RB, Uhrenfeldt L.

JBI Database System Rev Implement Rep. 2016 Sep;14(9):85-92.

PMID:
27755320
4.

Use of diagnostic coronary angiography in women and men presenting with acute myocardial infarction: a matched cohort study.

Bjerking LH, Hansen KW, Madsen M, Jensen JS, Madsen JK, Sørensen R, Galatius S.

BMC Cardiovasc Disord. 2016 Jun 1;16:120. doi: 10.1186/s12872-016-0248-9.

5.

Long-term outcomes in patients with rheumatologic disorders undergoing percutaneous coronary intervention: a BAsel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination (BASKET-PROVE) sub-study.

Nochioka K, Biering-Sørensen T, Hansen KW, Sørensen R, Pedersen S, Jørgensen PG, Iversen A, Shimokawa H, Jeger R, Kaiser C, Pfisterer M, Galatius S; BASKET-PROVE Investigators..

Eur Heart J Acute Cardiovasc Care. 2016 May 10. pii: 2048872616649860. [Epub ahead of print]

PMID:
27166320
6.

Effectiveness of an early versus a conservative invasive treatment strategy in acute coronary syndromes: a nationwide cohort study.

Hansen KW, Sorensen R, Madsen M, Madsen JK, Jensen JS, von Kappelgaard LM, Mortensen PE, Lange T, Galatius S.

Ann Intern Med. 2015 Nov 17;163(10):737-46. doi: 10.7326/M15-0303.

PMID:
26502223
7.
8.

Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction.

Schjerning Olsen AM, Gislason GH, McGettigan P, Fosbøl E, Sørensen R, Hansen ML, Køber L, Torp-Pedersen C, Lamberts M.

JAMA. 2015 Feb 24;313(8):805-14. doi: 10.1001/jama.2015.0809.

PMID:
25710657
9.

[Magnetic resonance imaging as supplement to clinical examination by suspicion of haematocolpos].

Rivero FY, Holst AK, Sørensen RG.

Ugeskr Laeger. 2015 Jan 26;177(2A):88-9. Danish.

PMID:
25612983
10.

Nationwide trends in use and timeliness of diagnostic coronary angiography in acute coronary syndromes from 2005 to 2011: Does distance to invasive heart centres matter?

Hansen KW, Sørensen R, Madsen M, Madsen JK, Jensen JS, von Kappelgaard LM, Mortensen PE, Galatius S.

Eur Heart J Acute Cardiovasc Care. 2015 Aug;4(4):333-43. doi: 10.1177/2048872614562968.

PMID:
25477476
11.

Tradeoff between bleeding and stent thrombosis in different dual antiplatelet therapy regimes: Importance of case fatality rates and effective treatment durations.

Jeger RV, Pfisterer ME, Sørensen R, von Felten S, Alber H, Bonetti PO, Eberli F, Erne P, Pedrazzini G, Rickli H, Galatius S, Kaiser CA; BASKET and BASKET-PROVE investigators..

Am Heart J. 2014 Nov;168(5):698-705. doi: 10.1016/j.ahj.2014.07.019.

PMID:
25440798
12.

Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.

Olesen JB, Sørensen R, Hansen ML, Lamberts M, Weeke P, Mikkelsen AP, Køber L, Gislason GH, Torp-Pedersen C, Fosbøl EL.

Europace. 2015 Feb;17(2):187-93. doi: 10.1093/europace/euu225.

13.

Risk and benefit of dual antiplatelet treatment among non-revascularized myocardial infarction patients in different age groups.

Juul N, Gislason G, Olesen JB, Lamberts M, Hansen ML, Karasoy D, Christiansen CB, Torp-Pedersen C, Sorensen R.

Eur Heart J Acute Cardiovasc Care. 2014 Jun 16. pii: 2048872614538848. [Epub ahead of print]

PMID:
24936092
14.

Triple antithrombotic therapy: risky but sometimes necessary.

Sørensen R, Gislason G.

Rev Esp Cardiol (Engl Ed). 2014 Mar;67(3):171-5. doi: 10.1016/j.rec.2013.08.010. No abstract available.

PMID:
24774390
15.

Drug-eluting stents and bare metal stents in patients with NSTE-ACS: 2-year outcome from the randomised BASKET-PROVE trial.

Pedersen SH, Pfisterer M, Kaiser C, Jensen JS, Alber H, Rickenbacher P, Sørensen R, Iversen A, Jensen MT, Wadt K, Galatius S; BASKET-PROVE Investigators..

EuroIntervention. 2014 May;10(1):58-64. doi: 10.4244/EIJV10I1A11.

16.

Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study.

Lamberts M, Gislason GH, Lip GY, Lassen JF, Olesen JB, Mikkelsen AP, Sørensen R, Køber L, Torp-Pedersen C, Hansen ML.

Circulation. 2014 Apr 15;129(15):1577-85. doi: 10.1161/CIRCULATIONAHA.113.004834.

17.

Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study.

Sørensen R, Gislason G, Torp-Pedersen C, Olesen JB, Fosbøl EL, Hvidtfeldt MW, Karasoy D, Lamberts M, Charlot M, Køber L, Weeke P, Lip GY, Hansen ML.

BMJ Open. 2013 May 3;3(5). pii: e002758. doi: 10.1136/bmjopen-2013-002758.

18.

Dysphagia screening and intensified oral hygiene reduce pneumonia after stroke.

Sørensen RT, Rasmussen RS, Overgaard K, Lerche A, Johansen AM, Lindhardt T.

J Neurosci Nurs. 2013 Jun;45(3):139-46. doi: 10.1097/JNN.0b013e31828a412c.

PMID:
23636069
19.

Prognosis and treatment in patients admitted with acute myocardial infarction on weekends and weekdays from 1997 to 2009.

Hansen KW, Hvelplund A, Abildstrøm SZ, Prescott E, Madsen M, Madsen JK, Jensen JS, Sørensen R, Galatius S.

Int J Cardiol. 2013 Sep 30;168(2):1167-73. doi: 10.1016/j.ijcard.2012.11.071.

PMID:
23199552
20.

Risk of bleeding related to antithrombotic treatment in cardiovascular disease.

Sørensen R, Olesen JB, Charlot M, Gislason GH.

Curr Pharm Des. 2012;18(33):5362-78. Review.

PMID:
22724419
Items per page

Supplemental Content

Loading ...
Support Center